ClinicalTrials.govpublic full text
The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients
ankylosing spondylitis, ankylosing spondylitis, nanocurcumin, microrna, th17 cells, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880238
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.